Clinuvel Pharmaceuticals Stock Quote UR9 - Stock Price, News, Charts, Message Board, Trades

Rendering Error

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

6.565

Bid

6.565

Ask

6.735

Volume

4,536

6.565 Day's Range 6.71

6.30 52 Week Range 10.79

Previous Close

6.76

Open

6.695

Last Trade

6.565

Last Trade Time

06:50:20

Average Volume (3m)

6,505

Financial Volume

VWAP

Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025

MELBOURNE, Australia, March 03, 2025 (GLOBE NEWSWIRE) -- World-leading photomedicine company CLINUVEL will...

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

MELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- CLINUVEL has filed a New Drug Submission (NDS) to...

Afamelanotide in fair-skinned Parkinson’s patients

MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program...

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL...

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an...

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March...

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

MELBOURNE, Australia, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Executive summaryPositive Results in the Half Year to...

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have...

CLINUVEL Trial Results Show Drug Reduces DNA Damage

MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair...

CLINUVEL progresses vitiligo treatment program

MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.035	-0.530303030303	6.6	7.135	6.525	4413	6.81431582	DE
4	-0.655	-9.07202216066	7.22	7.76	6.515	6737	6.92621479	DE
12	-0.57	-7.98878766643	7.135	7.76	6.3	6505	6.9731322	DE
26	-2.17	-24.8425872925	8.735	9.145	6.3	6679	7.45826861	DE
52	-2.7149999	-29.2564647549	9.2799999	10.79	6.3	5923	8.22088166	DE
156	-4.63	-41.3577489951	11.195	11.395	6.3	6147	8.70327027	DE
260	-4.63	-41.3577489951	11.195	11.395	6.3	6147	8.70327027	DE

UR9 - Frequently Asked Questions (FAQ)

What is the current Clinuvel Pharmaceuticals share price?

The current share price of Clinuvel Pharmaceuticals is 6.565 €

What is the 1 year trading range for Clinuvel Pharmaceuticals share price?

Clinuvel Pharmaceuticals has traded in the range of 6.30 € to 10.79 € during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
L7C2Windfall Geotek Inc	0.02 € (135.29%)	10.77k
AMIMedondo Holding AG	0.488 € (92.13%)	123
9E80Fortnox AB	8.04 € (33.69%)	11.18k
MK60QuantaSing Group Ltd	4.06 € (27.67%)	1.26k
07WAMr Cooper Group Inc	121.00 € (25.31%)	1.89k
7KOCullinan Metals Corp	0.0022 € (-80.70%)	9.8k
A4YACCENTRO Real Estate AG	0.055 € (-74.54%)	42.77k
E7TAlexium International Group Share	0.003 € (-40.00%)	24.79k
JWG1John Wood Group Plc	0.312 € (-35.91%)	10.3k
E092Hybrid Power Solutions Inc	0.027 € (-28.00%)	3k
3CPXiaomi Corporation	5.725 € (-3.49%)	2.86M
D7GNel ASA	0.2053 € (-4.91%)	2.27M
FMKEcograf Limited	0.18 € (17.26%)	2.22M
TUI1Tui AG	6.296 € (-6.00%)	1.3M
LHADeutsche Lufthansa AG	6.672 € (-5.01%)	988.99k